Safety and Pharmacokinetics of Single Doses of (+)-Calanolide A, a Novel, Naturally Occurring Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy, Human Immunodeficiency Virus-Negative Human Subjects

(+)-Calanolide A is a novel, naturally occurring, nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase first isolated from a tropical tree (Calophyllum lanigerum) in the Malaysian rain forest. Previous studies have demonstrated that (+)-calanolide A has specif...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Creagh, Terri, Ruckle, Jon L., Tolbert, Dwain T., Giltner, Jeremy, Eiznhamer, David A., Dutta, Bipul, Flavin, Michael T., Xu, Ze-Qi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Pharmacology
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90477/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11302799/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.5.1379-1386.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!